Growth Metrics

Palvella Therapeutics (PVLA) Net Income towards Common Stockholders Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -58.11%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -95.76%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -290.15%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 59.59%
7 Evaxion A 62.56 Bn 62.54 Bn - -129.68%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,228.66%
10 Palvella Therapeutics 1.47 Bn 1.21 Bn - -92.63%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -92.63%
Dec 31, 2025 962.72%
Sep 30, 2025 -62.79%
Jun 30, 2025 -116.93%
Mar 31, 2025 -199.82%
Dec 31, 2024 -125.17%
Sep 30, 2024 38.10%
Jun 30, 2024 -271.01%
Mar 31, 2024 81.98%
Sep 30, 2023 5.61%
Jun 30, 2023 120.93%
Mar 31, 2023 -103.14%
Sep 30, 2022 37.25%
Jun 30, 2022 27.21%
Mar 31, 2022 -47.55%
Dec 31, 2021 11.27%
Sep 30, 2021 -46.85%
Jun 30, 2021 -270.26%
Mar 31, 2021 -42.95%
Dec 31, 2020 -1,508.69%
Sep 30, 2020 -399.38%
Jun 30, 2020 61.51%
Mar 31, 2020 65.82%
Dec 31, 2019 93.40%
Sep 30, 2019 57.87%
Jun 30, 2019 -5,692.12%
Mar 31, 2019 -18.75%
Dec 31, 2018 -255.95%
Sep 30, 2018 12.83%
Jun 30, 2018 97.99%
Mar 31, 2018 -9.01%
Dec 31, 2017 217.11%
Sep 30, 2017 -13.92%
Jun 30, 2017 -71.42%
Mar 31, 2017 -92.11%
Dec 31, 2016 -120.44%
Sep 30, 2016 -57.98%
Jun 30, 2016 -66.66%
Mar 31, 2016 -12.32%
Sep 30, 2015 -93.96%
Jun 30, 2015 -22.50%
Mar 31, 2015 -375.02%
Sep 30, 2014 -34,994.59%
Jun 30, 2014 -1,051,585.77%